Diabetes mellitus and hyperglycemic complications in bullous pemphigoid - 14/04/20
Doi : 10.1016/j.jaad.2019.11.018
Zi Teng Chai, MD, MRCP a, Colin Tan, MBBS, MRCS (Edinburgh) b, May MeiQi Liau, MBChB, MRCP c, Harsharon Kaur, MBBS c, Shiu Ming Pang, MBBS, FRCP, FAMS (Dermatology) a, Yee Wei Phoon, MBBS, MMed, MRCP, FAMS (Dermatology) d, Nisha Suyien Chandran, MBBS, MMed, MRCP, FAMS (Dermatology) c, Haur Yueh Lee, MBBS, MMed, MRCP, FAMS (Dermatology) a, ⁎ 
a Department of Dermatology, Singapore General Hospital, Singapore
b Department of Dermatology, KK Women's and Children's Hospital Singapore, Singapore
c Division of Dermatology, University Medicine Cluster, National University Hospital, Singapore
d Department of Dermatology, Sengkang General Hospital, Singapore
∗Reprint requests: Haur Yueh Lee, Department of Dermatology, 20 College Rd, Singapore 168856Department of Dermatology20 College Rd168856Singapore
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 5
P. 1234-1237 - mai 2020 Retour au numéro
Article précédent
- Patients with hidradenitis suppurativa may suffer from neuropathic pain: A Finnish multicenter study
- Laura Huilaja, Mirkka J. Hirvonen, Tiina Lipitsä, Armi Vihervaara, Rauno Harvima, Harri Sintonen, Jukka Pekka Kouri, Martta Ranta, Rafael Pasternack
- Clinical outcome and safety of rituximab therapy for pemphigoid diseases
- Napatra Tovanabutra, Aimee S. Payne
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?